The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
Abstract In the past decade, the oncology community has witnessed major advances in the understanding of cancer biology and major breakthroughs in several different therapeutic areas, from solid tumors to hematological malignancies; moreover, the advent of effective immunotherapy approaches, such as...
Main Authors: | Talia Golan, Michele Milella, Aliza Ackerstein, Ranaan Berger |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-017-0668-0 |
Similar Items
-
Lights and Shadows in Immuno-Oncology Drug Development
by: Milana Bergamino Sirvén, et al.
Published: (2021-02-01) -
Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application
by: Shijia ZHANG, et al.
Published: (2017-09-01) -
A novel design for randomized immuno-oncology clinical trials with potentially delayed treatment effects
by: Pei He, et al.
Published: (2015-10-01) -
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
by: Philippe Merle
Published: (2021-01-01) -
The Expanding Role of the Oncology Pharmacist
by: Lisa M. Holle, et al.
Published: (2020-07-01)